Innovation at Cleveland Clinic

Innovation at Cleveland Clinic

Cleveland Clinic is home to many major medical breakthroughs in its history, ranging from the first First coronary angiography (1952) to the discovery of an intestinal bacteria product (TMAO) that can predict heart disease risk (2013). Cleveland Clinic discoveries and innovations are born out of a renowned culture in which critical mass is deployed to continually advance patient care. Cleveland Clinic Innovations (CCI) and Cleveland Clinic Ventures (CCV) work together to assess, protect, build, test and market the most promising ideas of our 51,000+ caregivers. This has resulted in a portfolio of over 1,200 issued patents, 550+ license agreements, and 80+ spin-off companies.

CCI

CCI

For nearly two decades, Cleveland Clinic has worked to transform and accelerate the way patient-benefiting technology is transferred from an academic institution to market. CCI’s robust team of market analysts, subject matter experts and former medical industry leaders is…

Read more

CCV

CCV

Cleveland Clinic forms and nurtures spin-off companies to advance the most scalable inventions of our caregivers. Since 2000, Cleveland Clinic Ventures has launched more than 80 companies.

Read more

Summit

Summit

MIS2020.

Read more

01/19/2021

COVID-19: Vaccines, Myths, & Masks

Following Emergency Use Authorization (EUA) from the FDA of COVID-19 vaccines in mid-December, Cleveland Clinic began its distribution of the limited doses received. Vaccinating according to a phased approach, with focus on frontline, inpatient-facing caregivers, the enterprise has worked overtime to distribute vaccines safely, equitably, and transparently while preserving the ability to maintain critical clinical operations.

01/13/2021

Top 10 for 2021: #1 | Gene Therapy for Hemoglobinopathies

Living with a condition with no known cure is the devastating reality for those patients suffering from these genetic disorders. Hemoglobin disorders, or hemoglobinopathies, arise when an individual's beta-globin gene is dysfunctional. The most common hemoglobinopathies include sickle cell disease and thalassemia – combined, affecting an estimated 330,000 kids born worldwide every year.

01/12/2021

With Bated Breath: Awaiting New Diagnostic Measures for COVID-19

Leveraging the ability to measure compounds in the breath known as volatile organic compounds, a team at Cleveland Clinic has developed a breath analysis test to capture vapor droplets and indicate the presence of particular compounds for the diagnosis of COVID-19.

Sign Up for Our Newsletter

Click below to be the first to know about upcoming events, programs, updates to the Medical Innovation Summit, and more!

Sign Up for our Newsletter

Top 10 Medical Innovations: 2021

View our list of the upcoming technologies that Cleveland Clinic experts predict will change patient care forever.

# 1 Gene Therapy for Hemoglobinopathies

#2 Drug for Primary-Progressive Multiple Sclerosis

#3 Smartphone-Connected Pacemaker Devices

#4 New Medication for Cystic Fibrosis

#5 Universal Hepatitis C Treatment

#6 Bubble CPAP for Increased Lung Function in Premature Babies

#7 Increased Access to Telemedicine through Novel Practice & Policy Changes

#8 Vacuum-Induced Uterine Tamponade Device for Postpartum Hemorrhage

#9 PARP Inhibitors for Prostate Cancer

#10 Immunologics for Migraine Prophylaxis

View All Innovations

Join the Conversation